[16日ロイター] - 米バイオ医薬品大手モデルナ(MRNA.O), opens new tabは16日、開発を進めている、メッセンジャーRNA（mRNA）テクノロジーに基づく季節性インフルエンザワクチンについて、臨床試験がまちまちだったと発表した。A型では強い ...
In this free webinar, gain insight into the principles of mRNA and LNP technology and their unique advantages for in vivo CAR T-cell development. Attendees will learn how mRNA synthesis, LNP ...
専門記者が最新動向を詳しく解説「世界を変える10大テクノロジー」、mRNAワクチン開発者のロングインタビューを敢行「mRNA治療の未来」株式会社角川アスキー総合研究所（本社：東京都文京区、代表取締役社長：加瀬典子）は、『MIT ...
The two-dose vaccine employs the same messenger RNA (mRNA)technology used in the COVID-19 shots developed by Pfizer with BioNTech, and by Moderna. It delivers tiny lipid particles containing mRNA ...
Researchers say the COVID-19 pandemic has provided an opportunity to boost a technology that may hold great promise for a new era of medicine. Watch the webinar mRNA technology has become a hot topic ...
[The content of this article has been produced by our advertising partner.] Since their emergency-use rollout in late 2020, billions of doses of COVID 19 vaccines built on disruptive mRNA technology ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する